Barinthus Biotherapeutics plc. (BRNS)
Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.
Address
UNIT 6-10, ZEUS BUILDING
DIDCOT, X0 OX11 0DF
Founded
2021
Number of Employees
130
Website
http://www.barinthusbio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)